Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients-Reference-Cited by-同舟云学术

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

Published:2014-10-06 Issue:7-8 Volume:15 Page:610-617
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Abe Koji¹,Itoyama Yasuto²,Sobue Gen³,Tsuji Shoji⁴,Aoki Masashi²,Doyu Manabu⁵,Hamada Chikuma⁶,Kondo Kazuoki⁷,Yoneoka Takatomo⁷,Akimoto Makoto⁷,Yoshino Hiide⁸,

Affiliation:

1. Department of Neurology, Okayama University Hospital, Okayama

2. Department of Neurology, Tohoku University Hospital, Sendai (Yasuto Itoyama is currently affiliated with International University of Health and Welfare, Ohtawara, Japan)

3. Department of Neurology, Nagoya University Hospital, Nagoya

4. Department of Neurology, The University of Tokyo Hospital, Tokyo

5. Department of Neurology, Aichi Medical University Hospital, Nagakute

6. Faculty of Engineering, Tokyo University of Science, Tokyo

7. Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo

8. Yoshino Neurology Clinic, Ichikawa, Japan

Publisher

Informa UK Limited

Subject

Clinical Neurology,Neurology

Link

https://www.tandfonline.com/doi/pdf/10.3109/21678421.2014.959024